Ivan V. Zelepukin

1.6k total citations · 2 hit papers
51 papers, 1.1k citations indexed

About

Ivan V. Zelepukin is a scholar working on Biomedical Engineering, Biomaterials and Molecular Biology. According to data from OpenAlex, Ivan V. Zelepukin has authored 51 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Biomedical Engineering, 21 papers in Biomaterials and 11 papers in Molecular Biology. Recurrent topics in Ivan V. Zelepukin's work include Nanoparticle-Based Drug Delivery (20 papers), Nanoplatforms for cancer theranostics (16 papers) and Laser-Ablation Synthesis of Nanoparticles (12 papers). Ivan V. Zelepukin is often cited by papers focused on Nanoparticle-Based Drug Delivery (20 papers), Nanoplatforms for cancer theranostics (16 papers) and Laser-Ablation Synthesis of Nanoparticles (12 papers). Ivan V. Zelepukin collaborates with scholars based in Russia, France and Sweden. Ivan V. Zelepukin's co-authors include Sergey M. Deyev, Maxim P. Nikitin, Petr I. Nikitin, Victoria O. Shipunova, Alexey V. Yaremenko, Aziz B. Mirkasymov, Konstantin G. Shevchenko, Ilya L. Sokolov, Andrei V. Kabashin and Anton A. Popov and has published in prestigious journals such as Nature Communications, ACS Nano and Advanced Drug Delivery Reviews.

In The Last Decade

Ivan V. Zelepukin

46 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery

2024 70 citations Ivan V. Zelepukin, Konstantin G. Shevchenko et al. Nature Communications profile →
Beyond the EPR effect: Intravital microscopy analysis of nanoparticle drug delivery to tumors

2025 33 citations Alexey V. Yaremenko, Sergey M. Deyev et al. Advanced Drug Delivery Reviews profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ivan V. Zelepukin Russia	19	626	438	335	270	126	51	1.1k
Victoria O. Shipunova Russia	19	629 1.0×	412 0.9×	578 1.7×	209 0.8×	189 1.5×	64	1.3k
Siti M. Janib United States	10	634 1.0×	681 1.6×	417 1.2×	310 1.1×	88 0.7×	11	1.4k
Sjoerd Hak Norway	19	559 0.9×	609 1.4×	448 1.3×	363 1.3×	149 1.2×	38	1.4k
Ara S. Moses United States	4	567 0.9×	533 1.2×	326 1.0×	297 1.1×	73 0.6×	4	1.2k
Cordula Gruettner United States	17	823 1.3×	685 1.6×	290 0.9×	194 0.7×	165 1.3×	22	1.3k
Rohan Bhavane United States	18	734 1.2×	414 0.9×	330 1.0×	410 1.5×	129 1.0×	31	1.4k
Pubudu M. Peiris United States	18	918 1.5×	791 1.8×	364 1.1×	327 1.2×	93 0.7×	24	1.5k
James Z. Hui United States	11	700 1.1×	610 1.4×	550 1.6×	287 1.1×	212 1.7×	15	1.4k
Beata Chertok United States	16	996 1.6×	1.1k 2.4×	398 1.2×	385 1.4×	88 0.7×	19	1.8k
Karina Pombo‐García Germany	9	354 0.6×	377 0.9×	426 1.3×	321 1.2×	47 0.4×	11	1.1k

Countries citing papers authored by Ivan V. Zelepukin

Since Specialization

Citations

This map shows the geographic impact of Ivan V. Zelepukin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan V. Zelepukin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan V. Zelepukin more than expected).

Fields of papers citing papers by Ivan V. Zelepukin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ivan V. Zelepukin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan V. Zelepukin. The network helps show where Ivan V. Zelepukin may publish in the future.

Co-authorship network of co-authors of Ivan V. Zelepukin

This figure shows the co-authorship network connecting the top 25 collaborators of Ivan V. Zelepukin. A scholar is included among the top collaborators of Ivan V. Zelepukin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ivan V. Zelepukin. Ivan V. Zelepukin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oroujeni, Maryam, Kristina Westerlund, Zhiguo Wang, et al.. (2025). Designed Ankyrin Repeat Protein–Mediated Peptide Nucleic Acid–Based Pretargeting: A Proof-of-Principle Study. Journal of Nuclear Medicine. 66(7). jnumed.125.269533–jnumed.125.269533.

Yaremenko, Alexey V., et al.. (2025). Beyond the EPR effect: Intravital microscopy analysis of nanoparticle drug delivery to tumors. Advanced Drug Delivery Reviews. 219. 115550–115550. 33 indexed citations breakdown →

Otvagin, Vasilii F., Natalia S. Kuzmina, Ivan V. Zelepukin, et al.. (2025). Developing Chlorin/Arylaminoquinazoline Conjugates with Nanomolar Activity for Targeted Photodynamic Therapy: Design, Synthesis, SAR, and Biological Evaluation. Journal of Medicinal Chemistry. 68(2). 1901–1923.

Zelepukin, Ivan V., et al.. (2025). A preclinical study on the influence of linkers in [68Ga]Ga-NOTA-X-RM26 radiotracers for PET imaging of GRPR expression. EJNMMI Research. 15(1). 104–104.

Zelepukin, Ivan V., Gleb V. Tikhonowski, Anton A. Popov, et al.. (2024). Laser-synthesized plasmonic HfN-based nanoparticles as a novel multifunctional agent for photothermal therapy. Nanoscale. 16(38). 17893–17907. 2 indexed citations

Demyashkin, Grigory, Anton A. Popov, Ivan V. Zelepukin, et al.. (2024). Bismuth Nanoparticles Increase Effectiveness of Proton Therapy of Ehrlich Carcinoma. Bulletin of Experimental Biology and Medicine. 176(5). 626–630.

Zelepukin, Ivan V., Konstantin G. Shevchenko, & Sergey M. Deyev. (2024). Rediscovery of mononuclear phagocyte system blockade for nanoparticle drug delivery. Nature Communications. 15(1). 4366–4366. 70 indexed citations breakdown →

Zelepukin, Ivan V., Polina A. Kotelnikova, Gleb V. Tikhonowski, et al.. (2024). Laser‐Synthesized Germanium Nanoparticles as Biodegradable Material for Near‐Infrared Photoacoustic Imaging and Cancer Phototherapy. Advanced Science. 11(20). e2307060–e2307060. 15 indexed citations

Popov, Anton L., Ivan V. Zelepukin, Gleb V. Tikhonowski, et al.. (2024). Boron Nanoparticle-Enhanced Proton Therapy: Molecular Mechanisms of Tumor Cell Sensitization. Molecules. 29(16). 3936–3936. 2 indexed citations

10.

Zavestovskaya, I. N., Gleb V. Tikhonowski, Anton A. Popov, et al.. (2023). Boron Nanoparticle-Enhanced Proton Therapy for Cancer Treatment. Nanomaterials. 13(15). 2167–2167. 11 indexed citations

11.

Бармина, Е. В., I. N. Zavestovskaya, О. В. Уваров, et al.. (2022). Laser ablation of Fe ₂ B target enriched in ¹⁰ B content for boron neutron capture therapy. Laser Physics Letters. 19(6). 66002–66002. 5 indexed citations

12.

Popov, Anton A., Żaneta Światkowska-Warkocka, M. Marszałek, et al.. (2022). Laser-Ablative Synthesis of Ultrapure Magneto-Plasmonic Core-Satellite Nanocomposites for Biomedical Applications. Nanomaterials. 12(4). 649–649. 22 indexed citations

13.

Novoselova, Marina V., Sergey V. German, Aleksei S. Komlev, et al.. (2022). CaCO₃ Nanoparticles Coated with Alternating Layers of Poly-L-Arginine Hydrochloride and Fe₃O₄ Nanoparticles as Navigable Drug Carriers and Hyperthermia Agents. ACS Applied Nano Materials. 5(2). 2994–3006. 21 indexed citations

14.

Mirkasymov, Aziz B., Ivan V. Zelepukin, D. Sh. Dzhalilova, et al.. (2022). Macrophage blockade using nature-inspired ferrihydrite for enhanced nanoparticle delivery to tumor. International Journal of Pharmaceutics. 621. 121795–121795. 14 indexed citations

15.

Yaremenko, Alexey V., Ivan V. Zelepukin, D. Sh. Dzhalilova, et al.. (2022). Influence of magnetic nanoparticle biotransformation on contrasting efficiency and iron metabolism. Journal of Nanobiotechnology. 20(1). 535–535. 17 indexed citations

16.

Прошкина, Г. М., Е. И. Шрамова, Ivan V. Zelepukin, et al.. (2021). DARPin_9-29-Targeted Gold Nanorods Selectively Suppress HER2-Positive Tumor Growth in Mice. Cancers. 13(20). 5235–5235. 19 indexed citations

17.

Shipunova, Victoria O., et al.. (2021). PLGA Nanoparticles Decorated with Anti-HER2 Affibody for Targeted Delivery and Photoinduced Cell Death. Molecules. 26(13). 3955–3955. 31 indexed citations

18.

Shipunova, Victoria O., Polina A. Kotelnikova, Ivan V. Zelepukin, et al.. (2020). Dual Regioselective Targeting the Same Receptor in Nanoparticle-Mediated Combination Immuno/Chemotherapy for Enhanced Image-Guided Cancer Treatment. ACS Nano. 14(10). 12781–12795. 45 indexed citations

19.

Zelepukin, Ivan V., Alexey V. Yaremenko, Mikhail Yuryev, et al.. (2020). Fast processes of nanoparticle blood clearance: Comprehensive study. Journal of Controlled Release. 326. 181–191. 66 indexed citations

20.

Mirkasymov, Aziz B., Ivan V. Zelepukin, Petr I. Nikitin, Maxim P. Nikitin, & Sergey M. Deyev. (2020). In vivo blockade of mononuclear phagocyte system with solid nanoparticles: Efficiency and affecting factors. Journal of Controlled Release. 330. 111–118. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact